Andrew M. Lowy - Concepedia

Author

Andrew M. Lowy

University of California San Diego ORCID

Also Known As

A Lowy, A M Lowy, A. Lowy, A. M. Lowy, A.M Lowy, A.M. Lowy, ANDREW M LOWY, ANDREW M. LOWY, Andreas Brandl, Andrew M. Lowy

831

Publications

23.5K

Citations

H-Index

139

Concepts

All Affiliations

University of California San Diego University of Cincinnati University of Cincinnati Medical Center The University of Texas MD Anderson Cancer Center Moores Cancer Center

About

Andrew M. Lowy is an author at University of California San Diego specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	43	96	10.5K
2	Health Sciences	11	11	1.7K
3	Engineering	3	3	415
4	Natural Sciences	3	3	122
5	Social Sciences	3	3	133

Andrew M. Lowy

177

Publications

19.9K

Citations

H-Index

Page 1

	Year	Citations
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse Sunil R. Hingorani, Emanuel F. Petricoin, Anirban Maitra, Cancer Cell Tumor BiologyPancreatic CancerMedicineHistopathologyGastroenterology	2003	2.5K
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology Margaret A. Tempero, Mokenge P. Malafa, Mahmoud M. Al-Hawary, Journal of the National Comprehensive Cancer Network	2021	1.2K
Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology Margaret A. Tempero, Mokenge P. Malafa, Mahmoud M. Al-Hawary, Journal of the National Comprehensive Cancer Network Surgical OncologyOncologic ImagingGastroenterologyPathologySurgery	2017	1K
Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer Jennifer P. Morton, Paul Timpson, Saadia A. Karim, Proceedings of the National Academy of Sciences	2009	673
Pancreatic Adenocarcinoma, Version 2.2014 Margaret A. Tempero, Mokenge P. Malafa, Stephen W. Behrman, Journal of the National Comprehensive Cancer Network Surgical OncologyCancer ManagementNccn Guidelines InsightsGastroenterologyPathology	2014	463
Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer Matthew H. G. Katz, Qian Shi, Syed A. Ahmad, JAMA Surgery	2016	443
Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring Yu Shi, Weina Gao, Nikki K. Lytle, Nature Tumor BiologyDrug TargetingPancreatic CancerLif-mediated Paracrine InteractionMedicine	2019	413
SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma Edgar Ben‐Josef, Katherine A. Guthrie, Anthony B. El-Khoueiry, Journal of Clinical Oncology	2015	395
Left-sided Pancreatectomy David A. Kooby, Theresa Gillespie, David J. Bentrem, Annals of Surgery	2008	388
Guidelines Insights: Pancreatic Adenocarcinoma, Version 1.2019 Margaret A. Tempero, Mokenge P. Malafa, E. Gabriela Chiorean, Journal of the National Comprehensive Cancer Network Surgical OncologyPancreatic CancerGuidelines InsightsGastrointestinal OncologyMedicine	2019	365

Page 1